GPX4-regulated ferroptosis is involved in cancer development and progression [54], drug-resistant persistent cells are highly dependent on GPX4 for survival, and loss of GPX4 function leads to cellular ferroptosis and prevents drug resistance; thus, a novel avenue of cancer therapy is proposed [55]. This evidence concerns the gene GPX4 and cancer.